AstraZeneca is to start clinical trials to test a combination of its experimental coronavirus vaccine with Russia's Sputnik V shot to see if this can boost the efficacy of the British drugmaker's ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A drug that AstraZeneca singled out as one of its key potential revenue growth drivers in the next decade has failed a pivotal study in light chain amyloidosis, a rare disease with few treatment ...
CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death ...
CEO Pascal Soriot lays out the role that AI could eventually have in detecting and monitoring cancer and other diseases, ...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. AstraZeneca reported mixed phase 3 data for efzimfotase alfa in hypophosphatasia, ...
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
CHICAGO - Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results